Research
And Grants
Note: When clicking the "Submit Grant Application" button below you will be redirected to SnapGrant.com to complete the application process.
Submit Grant ApplicationThe Cure Starts Now has funded $25,395,277 (USD) in pediatric brain cancer research in partnership with the DIPG / DMG Collaborative. This includes 167 grants at over 100 hospitals in 29 countries.

UPMC Children's Hospital – $50,000
$50,000.00
September 2021
The Role of QPRT and NAD Pathways in DIPG Treatment Resistance

University of Queensland Diamantina Institute – $100,000
$100,000.00
September 2021
Innovative Models of the Brain Microenvironment to Identify New Treatments for Medulloblastoma

Duke University Hospital – $50,000
$50,000.00
September 2021
Identifying Oncolytic Viral Therapy Resistance Mechanisms in Brain Tumors

Funding of PBTCF 2021: PBTC-059 - $25,000
$25,000.00
January 2021
Phase 1 Trial of Autologous HER2-specific CAR T cells in Pediatric Patients with Refractory or Recurrent Ependymoma

International DIPG/DMG Registry And Repository - $1,508,198
$1,508,198.00
December 2020

Children's Cancer Institute - $99,251
$99,251.00
September 2020
Discovering New Epigenetic Players in DIPG Oncogenesis

Northwestern Memorial Hospital - $110,000
$110,000.00
September 2020
Development of Histone Demethylase Inhibitor Against DIPG

The Hospital for Sick Children - $100,000
$100,000.00
September 2020
Methionne Deptrivation as a Therapeutic Strategy for Diffuse Intrinsic Pontine Glioma

Hunter Medical Research Institute - $145,640
$145,640.00
September 2020
Combatt DMG: Combined Anti-tumor Targeting of Diffuse Midline Gliomas

CONNECT Consortium - $489,801.26
$489,801.00
September 2020
CONNECT (COllaborative Network for NEurooncology Clinical Trials) Consortium

International DIPG/DMG Registry And Repository - $862,671
$862,671.00
May 2020

Funding of PBTCF 2020: PBTC-058 - $25,000
$25,000.00
January 2020
PBTC-058: Phase 2 Study of Intraventricular Omburtamab-based Radioimmunotherapy for Pediatric Patients with Recurrent Medulloblastoma and Ependymoma

Sydney Children's Hospital - $151,468
$151,468.00
December 2019
Developing New Epigenetic Combination Treatments Against DIPG.

Oncoceutics ONC201 - $100,000
$100,000.00
December 2019
Expansion of the ONC201 Compassionate Use.

University of Sydney - $100,000
$100,000.00
November 2019
Targeting hypoxia and mitochondrial metabolism with repurposing drugs as an approach of radiosensitization for diffuse intrinsic pontine gliomas.